 | • レポートコード：QYR9NV10969 • 出版社/出版日：QYResearch / 2019年11月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、核医学における放射性医薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、診断用放射性医薬品、治療用放射性医薬品、濃縮安定同位体に、用途別には、診断用、治療用、研究、医薬品、産業にセグメント区分し、核医学における放射性医薬品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・核医学における放射性医薬品の世界市場概要 ・核医学における放射性医薬品の製造コスト構成分析 ・核医学における放射性医薬品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・核医学における放射性医薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・核医学における放射性医薬品のセグメント分析（種類別） （診断用放射性医薬品、治療用放射性医薬品、濃縮安定同位体） ・核医学における放射性医薬品のセグメント分析（用途別） （診断用、治療用、研究、医薬品、産業） ・核医学における放射性医薬品の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Bracco Imaging、Cambridge Isotope Laboratories、Cardinal Health、Covidien、Eczacibasi-Monrol、Fujifilm Holdings Corporation、GE Healthcare (Subsidiary Of General Electric Company)、IBA Group、Lantheus Medical Imaging、Nordion、Ntp Radioisotopes、Siemens Healthcare、Taiyo Nippon Sanso Corporation、Urenco Limited、Rotem Industries、） ・核医学における放射性医薬品の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Radiopharmaceuticals in Nuclear Medical market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Radiopharmaceuticals in Nuclear Medical volume and value at global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceuticals in Nuclear Medical market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Radiopharmaceuticals in Nuclear Medical in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Radiopharmaceuticals in Nuclear Medical manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Covidien
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Segment by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
Table of Contents
Executive Summary
1 Industry Overview of Radiopharmaceuticals in Nuclear Medical
1.1 Definition of Radiopharmaceuticals in Nuclear Medical
1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medical Segment by Applications
1.3.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Comparison by Applications (2014-2025)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Global Radiopharmaceuticals in Nuclear Medical Overall Market
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Revenue (2014-2025)
1.4.2 Global Radiopharmaceuticals in Nuclear Medical Production (2014-2025)
1.4.3 North America Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.4 Europe Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.5 China Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.6 Japan Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.7 Southeast Asia Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.8 India Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical
2.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
2.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
3 Development and Manufacturing Plants Analysis of Radiopharmaceuticals in Nuclear Medical
3.1 Capacity and Commercial Production Date
3.2 Global Radiopharmaceuticals in Nuclear Medical Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Radiopharmaceuticals in Nuclear Medical
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Radiopharmaceuticals in Nuclear Medical Production and Capacity Analysis
4.2 Radiopharmaceuticals in Nuclear Medical Revenue Analysis
4.3 Radiopharmaceuticals in Nuclear Medical Price Analysis
4.4 Market Concentration Degree
5 Radiopharmaceuticals in Nuclear Medical Regional Market Analysis
5.1 Radiopharmaceuticals in Nuclear Medical Production by Regions
5.1.1 Global Radiopharmaceuticals in Nuclear Medical Production by Regions
5.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions
5.2 Radiopharmaceuticals in Nuclear Medical Consumption by Regions
5.3 North America Radiopharmaceuticals in Nuclear Medical Market Analysis
5.3.1 North America Radiopharmaceuticals in Nuclear Medical Production
5.3.2 North America Radiopharmaceuticals in Nuclear Medical Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Radiopharmaceuticals in Nuclear Medical Import and Export
5.4 Europe Radiopharmaceuticals in Nuclear Medical Market Analysis
5.4.1 Europe Radiopharmaceuticals in Nuclear Medical Production
5.4.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Radiopharmaceuticals in Nuclear Medical Import and Export
5.5 China Radiopharmaceuticals in Nuclear Medical Market Analysis
5.5.1 China Radiopharmaceuticals in Nuclear Medical Production
5.5.2 China Radiopharmaceuticals in Nuclear Medical Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Radiopharmaceuticals in Nuclear Medical Import and Export
5.6 Japan Radiopharmaceuticals in Nuclear Medical Market Analysis
5.6.1 Japan Radiopharmaceuticals in Nuclear Medical Production
5.6.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Radiopharmaceuticals in Nuclear Medical Import and Export
5.7 Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Analysis
5.7.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Production
5.7.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Radiopharmaceuticals in Nuclear Medical Import and Export
5.8 India Radiopharmaceuticals in Nuclear Medical Market Analysis
5.8.1 India Radiopharmaceuticals in Nuclear Medical Production
5.8.2 India Radiopharmaceuticals in Nuclear Medical Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Radiopharmaceuticals in Nuclear Medical Import and Export
6 Radiopharmaceuticals in Nuclear Medical Segment Market Analysis (by Type)
6.1 Global Radiopharmaceuticals in Nuclear Medical Production by Type
6.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type
6.3 Radiopharmaceuticals in Nuclear Medical Price by Type
7 Radiopharmaceuticals in Nuclear Medical Segment Market Analysis (by Application)
7.1 Global Radiopharmaceuticals in Nuclear Medical Consumption by Application
7.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2014-2019)
8 Radiopharmaceuticals in Nuclear Medical Major Manufacturers Analysis
8.1 Bracco Imaging
8.1.1 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.1.2 Bracco Imaging Product Introduction, Application and Specification
8.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Cambridge Isotope Laboratories
8.2.1 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.2.2 Cambridge Isotope Laboratories Product Introduction, Application and Specification
8.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cardinal Health
8.3.1 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.3.2 Cardinal Health Product Introduction, Application and Specification
8.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Covidien
8.4.1 Covidien Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.4.2 Covidien Product Introduction, Application and Specification
8.4.3 Covidien Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eczacibasi-Monrol
8.5.1 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.5.2 Eczacibasi-Monrol Product Introduction, Application and Specification
8.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Fujifilm Holdings Corporation
8.6.1 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.6.2 Fujifilm Holdings Corporation Product Introduction, Application and Specification
8.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GE Healthcare (Subsidiary Of General Electric Company)
8.7.1 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Introduction, Application and Specification
8.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 IBA Group
8.8.1 IBA Group Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.8.2 IBA Group Product Introduction, Application and Specification
8.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Lantheus Medical Imaging
8.9.1 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.9.2 Lantheus Medical Imaging Product Introduction, Application and Specification
8.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Nordion
8.10.1 Nordion Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.10.2 Nordion Product Introduction, Application and Specification
8.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Ntp Radioisotopes
8.12 Siemens Healthcare
8.13 Taiyo Nippon Sanso Corporation
8.14 Urenco Limited
8.15 Rotem Industries
9 Development Trend of Analysis of Radiopharmaceuticals in Nuclear Medical Market
9.1 Global Radiopharmaceuticals in Nuclear Medical Market Trend Analysis
9.1.1 Global Radiopharmaceuticals in Nuclear Medical Market Size (Volume and Value) Forecast 2019-2025
9.2 Radiopharmaceuticals in Nuclear Medical Regional Market Trend
9.2.1 North America Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.2 Europe Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.3 China Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.4 Japan Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.5 Southeast Asia Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.6 India Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.3 Radiopharmaceuticals in Nuclear Medical Market Trend (Product Type)
9.4 Radiopharmaceuticals in Nuclear Medical Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Radiopharmaceuticals in Nuclear Medical Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Radiopharmaceuticals in Nuclear Medical
Table Global Radiopharmaceuticals in Nuclear Medical Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Types in 2018
Figure Diagnostic Radiopharmaceuticals Product Picture
Figure Therapy Radiopharmaceuticals Product Picture
Figure Enriched Stable Isotopes Product Picture
Table Global Radiopharmaceuticals in Nuclear Medical Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Applications in 2018
Figure Diagnostic Application
Figure Therapeutic Application
Figure Research
Figure Pharmaceutical
Figure Industrial
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Production (K Units) (2014-2025)
Figure North America Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure Europe Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure China Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure Japan Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure India Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Table Radiopharmaceuticals in Nuclear Medical Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical in 2018
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Radiopharmaceuticals in Nuclear Medical Manufacturing Plants Distribution
Table Radiopharmaceuticals in Nuclear Medical Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Radiopharmaceuticals in Nuclear Medical Capacity (K Units) of Major Manufacturers (2014-2019)
Table Radiopharmaceuticals in Nuclear Medical Production (K Units) of Major Manufacturers (2014-2019)
Table Radiopharmaceuticals in Nuclear Medical Production Market Share of Major Manufacturers (2014-2019)
Figure Radiopharmaceuticals in Nuclear Medical Production Share by Manufacturers in 2018
Table Radiopharmaceuticals in Nuclear Medical Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Radiopharmaceuticals in Nuclear Medical Revenue Market Share of Major Manufacturers (2014-2019)
Figure Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers in 2018
Table Radiopharmaceuticals in Nuclear Medical Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Radiopharmaceuticals in Nuclear Medical Production by Regions 2014-2019 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Regions 2014-2019
Figure Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Regions in 2018
Table Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions 2014-2019 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions 2014-2019
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions in 2018
Table Global Radiopharmaceuticals in Nuclear Medical Consumption by Regions 2014-2019 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions 2014-2019
Figure North America Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table North America Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table China Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table India Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Global Consumption Radiopharmaceuticals in Nuclear Medical Market Share by Application (2014-2019)
Figure Global Value (Consumption) Radiopharmaceuticals in Nuclear Medical Market Share by Application (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Bracco Imaging Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Cardinal Health Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Covidien Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Covidien Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Covidien Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Covidien Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Covidien Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Covidien Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Covidien Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table IBA Group Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure IBA Group Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table IBA Group Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Nordion Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Nordion Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Nordion Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Nordion Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Nordion Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Nordion Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Nordion Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Urenco Limited Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Rotem Industries Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Figure Global Radiopharmaceuticals in Nuclear Medical Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Radiopharmaceuticals in Nuclear Medical by Type (2019-2025)
Table Global Consumption (K Units) of Radiopharmaceuticals in Nuclear Medical by Application (2019-2025)
Table Radiopharmaceuticals in Nuclear Medical Distributors List
Table Radiopharmaceuticals in Nuclear Medical Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
核医学における放射性医薬品のグローバル市場調査 2019年 The global Radiopharmaceuticals in Nuclear Medical market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Radiopharmaceuticals in Nuclear Medical volume and value at global level, regional level and compan…- PET放射性医薬品のグローバル市場調査 2019年 The global PET Radiopharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on PET Radiopharmaceuticals volume and value at global level, regional level and company level. From a global perspec…
- 核医学＆放射性医薬品のグローバル市場調査 2019年 The global Nuclear Medicine & Radio Pharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nuclear Medicine & Radio Pharmaceuticals volume and value at global level, regional level and comp…
- 核イメージングシステムのグローバル市場調査 2019年 The global Nuclear Imaging Systems market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nuclear Imaging Systems volume and value at global level, regional level and company level. From a global perspecti…
- 原子力発電のグローバル市場：規模・現状・予測2019-2025 Nuclear power is a low-carbon source of electricity that plays a key role in the energy transition. It supports everyday electricity supply and the continued electrification of society with fossil free power. For decades to come long-term nuclear operations will continue to play an important role in…